Literature DB >> 25786597

Magnetic nanoparticles and their applications in image-guided drug delivery.

Mi Kyung Yu1, Jinho Park, Sangyong Jon.   

Abstract

Magnetic iron oxide nanoparticles have been shown to be suitable for use as theranostic agents owing to their intrinsic diagnostic capabilities in magnetic resonance imaging (MRI) applications, hyperthermia properties, and ability to deliver drugs via magnetic attraction and/or systemic delivery. In addition, surface modifications are easily introduced through conjugation with targeting moieties (e.g., antibodies, peptides, or aptamers), genes, or therapeutic drugs to provide multimodal functionalities. Such valuable characteristics apply to image-guided drug delivery, especially MRI-guided drug delivery-a form of individualized therapy in which imaging methods are used to guide and monitor delivery of therapeutic agents to target tissues. This review summarizes the intrinsic physicochemical properties and pharmacokinetics of magnetic nanoparticles and highlights recent reports describing theranostic systems, including magnetic nanoparticle-based nanoplatforms, and their applications in MRI-guided drug delivery.

Entities:  

Year:  2012        PMID: 25786597     DOI: 10.1007/s13346-011-0049-8

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  78 in total

1.  Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.

Authors:  Hao-Li Liu; Mu-Yi Hua; Hung-Wei Yang; Chiung-Yin Huang; Po-Chun Chu; Jia-Shin Wu; I-Chou Tseng; Jiun-Jie Wang; Tzu-Chen Yen; Pin-Yuan Chen; Kuo-Chen Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

2.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  Evaluation of quantum dot cytotoxicity based on intracellular uptake.

Authors:  Emmanuel Chang; Nadhi Thekkek; William W Yu; Vicki L Colvin; Rebekah Drezek
Journal:  Small       Date:  2006-12       Impact factor: 13.281

4.  Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.

Authors:  Kullervo Hynynen; Nathan McDannold; Natalia Vykhodtseva; Scott Raymond; Ralph Weissleder; Ferenc A Jolesz; Nickolai Sheikov
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

5.  Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.

Authors:  Ana M Ponce; Benjamin L Viglianti; Daohai Yu; Pavel S Yarmolenko; Charles R Michelich; Janet Woo; Marcel B Bally; Mark W Dewhirst
Journal:  J Natl Cancer Inst       Date:  2007-01-03       Impact factor: 13.506

Review 6.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

7.  pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI.

Authors:  Eun-Kyung Lim; Yong-Min Huh; Jaemoon Yang; Kwangyeol Lee; Jin-Suck Suh; Seungjoo Haam
Journal:  Adv Mater       Date:  2011-04-14       Impact factor: 30.849

8.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

9.  Image-guided breast tumor therapy using a small interfering RNA nanodrug.

Authors:  Mohanraja Kumar; Mehmet Yigit; Guangping Dai; Anna Moore; Zdravka Medarova
Journal:  Cancer Res       Date:  2010-08-11       Impact factor: 12.701

10.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

Authors:  A S Lübbe; C Bergemann; H Riess; F Schriever; P Reichardt; K Possinger; M Matthias; B Dörken; F Herrmann; R Gürtler; P Hohenberger; N Haas; R Sohr; B Sander; A J Lemke; D Ohlendorf; W Huhnt; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

View more
  2 in total

Review 1.  Nanotechnology for protein delivery: Overview and perspectives.

Authors:  Mikyung Yu; Jun Wu; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2015-10-13       Impact factor: 9.776

2.  Thermo-responsive Fluorescent Nanoparticles for Multimodal Imaging and Treatment of Cancers.

Authors:  Nikhil Pandey; Jyothi U Menon; Masaya Takahashi; Jer-Tsong Hsieh; Jian Yang; Kytai T Nguyen; Aniket S Wadajkar
Journal:  Nanotheranostics       Date:  2020-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.